Landscape Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Landscape Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,859	Closed	-$774K	–	934
2025 Q4	$774K	Buy	+22,859	New	+$710K	0.05%	408

Landscape Capital Management's RAPT Position: Q1 2026 in Review

Landscape Capital Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 22,859 shares — an estimated $774K sold.

Landscape Capital Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $774K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Landscape Capital Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Landscape Capital Management sold 22,859 RAPT Therapeutics shares in Q1 2026, an estimated $774K.
Landscape Capital Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Landscape Capital Management's RAPT Therapeutics position peaked at $774K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.